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Abstract
Introduction
Chronic cough is a distressing symptom and a common reason for people to seek health
care services. It is a symptom that can indicate underlying tuberculosis (TB) and/or chronic
airways diseases (CAD) including asthma, chronic obstructive pulmonary disease (COPD)
and bronchiectasis. In developing countries including Malawi, provision of diagnostic ser-
vices and clinical management of CAD is rudimentary, so it is thought that patients make
costly and unyielding repeated care-seeking visits. There is, however, a lack of information
on cost of illness, both direct and indirect, to patients with chronic cough symptom. Such
data are needed to inform policy-makers in making decisions on allocating resources for
designing and developing the relevant health care services to address universal coverage
programmes for CAD. This paper therefore explores health seeking costs associated with
chronic cough and explores information on usage of the coping mechanisms which indicate
financial hardship, such as borrowing and selling household assets.
Methods
This economic study was nested within a community-based, population-proportional
cross-sectional survey of 15,795 individuals aged 15 years and above, in Dowa and
Ntchisi districts. The study sought to identify individuals with symptoms of chronic airways
disease whose health records documented at least one of the following diagnoses within
the previous year: TB, Asthma, COPD, Bronchitis and Lower Respiratory Tract Infection
(LRTI). We interviewed these chronic coughers to collect information on socioeconomic
and socio-demographic characteristics, health care utilization, and associated costs of
care in 2015. We also collected information on how they funded their health seeking
costs.
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Results
We identified 608 chronic coughers who reported costs in relation to their latest confirmed
diagnosis in their hand-held health record. The mean care-seeking cost per patient was US
$ 3.9 (95% CI: 3.00–5.03); 2.3 times the average per capita expenditure on health of US$
1.69. The largest costs were due to transport (US$ 1.4), followed by drugs (US$ 1.3). The
costs of non-medical inputs (US$ 2.09) was considerable (52.3%). Nearly a quarter (24.4%)
of all the patients reportedly borrowed or/and sold assets/property to finance their health-
care. CCs with COPD and LRTI had 85.6% and 62.0% lower chance of incurring any costs
compared with the TB patients and any patients with comorbidity had 2.9 times higher
chance to incur any costs than the patients with single disease. COPD, Bronchitis and LRTI
patients had 123.9%, 211.4% and 87.9% lower costs than the patients with TB. The patients
with comorbidity incurred 53.9% higher costs than those with single disease.
Conclusions
The costs of healthcare per chronic cougher was mainly influenced by the transport and
drugs costs. Types of diseases and comorbidity led to significantly different chances of
incurring costs as well as difference in magnitude of costs. The costs appeared to be unaf-
fordable for many patients.
Introduction
Tuberculosis and chronic airway diseases (CAD) including asthma, chronic obstructive pul-
monary disease (COPD) and bronchiectasis represent a major disease burden to most develop-
ing countries, particularly in Sub-Saharan Africa [1–4]. COPD and asthma are estimated to
affect 64 million and 235 million people worldwide, respectively [3]. A diagnosis for people
with chronic or persistent cough is usually delayed because of individual and health system
barriers. Unfortunately, delayed diagnosis and treatment of TB, COPD and asthma facilitates
further TB transmission, severity of disease with complications and increased mortality. In the
latest estimates by World Health Organisation, COPD was the fourth leading cause of deaths
in 2004, and in 2030, it is projected to become the third leading cause, with 5.8 million or 8.6%
of the total deaths [3].
It has been estimated that, asthma morbidity and mortality accounts for around 1% of all
disability-adjusted life years (DALYs), equivalent to 16 million DALYs lost per year worldwide
[3]. A crucial point is that all respiratory diseases, if not diagnosed, treated and managed
promptly and correctly, are problematic for individuals and health systems alike [5].
Furthermore, COPD is characterized by airflow limitation that is not fully reversible but
nonetheless treatable. The World Health Organization (WHO) estimates that 65 million peo-
ple have moderate to severe COPD with 5% of all (3 million) global deaths being attributed to
COPD [6]. About 90% of these COPD deaths occur in low-income and middle-income coun-
tries. At the other end of the spectrum, asthma, a chronic inflammatory disorder of the air-
ways, is characterized by episodes of reversible breathing problems (that may be life-
threatening) due to airway narrowing and obstruction. These episodes are characterized by
coughing, wheezing, chest tightness and shortness of breath. The frequency and severity of
these episodes can have a marked impact on the livelihoods and the well-being of those
affected [7]. Bronchiectasis is a severe, chronic infection of the lung associated with permanent
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abnormal dilatation of bronchi [8]. As a result, mucus clearance is impaired, leading to accu-
mulation of secretions, bacterial overgrowth and recurrent infections.
Health seeking costs associated with chronic cough (CC) are estimated to rank as one of the
highest among chronic diseases due to the significant health care utilisation associated with
these conditions [9,10]. Severe and poorly controlled chronic cough is believed to have a high
economic burden both directly (hospitalisation, diagnostic tests and medicines) and indirectly
(productivity loss) [9–12]. In addition, chronic cough is also associated with the loss of future
potential earnings related to morbidity and mortality. ‘
Numerous studies have been published evaluating health seeking costs of CC in high
income countries [13–16, 17] however, a dearth of evidence exists on similar studies in low
income countries [9, 18–20]. In order to address the major CC challenges that threaten health
and economies alike in low income settings, it is important to have information on the type
and extent of costs incurred by different groups of individuals affected by chronic cough [9,
21–25].
This is important given that in low income settings, relatively small costs on health can be
disastrous and lead to catastrophic healthcare expenditure [10–12]. This implies that the cost
of regular chronic cough diagnosis and treatment could be unaffordable to families in low
income settings. One challenge that policy makers face is the lack of cost data to inform the
design and provision of universal coverage programs for core health service responses to
chronic cough [9, 10 and 12]
Objectives
The main objective of this paper is to explore health seeking costs incurred by chronic cough-
ers starting from the onset of symptoms, to diagnosis and the management of the illness. This
is the cost of the whole care-seeking process which includes pre-diagnostics and diagnostic
costs, treatment costs, hospitalisation costs as well as guardians (accompanied persons) costs.
To reach the main objective, we set out to estimate the direct costs (medical and non-medical)
associated with chronic cough, estimate variations in these costs across socio-economic and
socio-demographic groups and to identify coping mechanisms with detrimental effects on eco-
nomic status of the chronic coughers.
Methods
Study design
This study was reviewed and approved by The College of Medicine Research and Ethics Com-
mittee (COMREC), which is situated within The University of Malawi, College of Medicine.
This is a local Institutional Review Board which approves research projects in Malawi. This
was a trial with the following approval number: P.07/13/1424 [17]. Participants signed consent
forms after agreeing to participate in the study on the basis of information provided by the
data collectors. For those less than 18 years, we obtained consent from parents first, before
seeking their individual consent and they signed consent form afterwards.
This cross-sectional community-based survey was conducted in 2015 (January to June) in
rural areas of two districts, namely, Dowa and Ntchisi, in the central region of Malawi. A total
of 15,795 individuals were included in the survey where household was the unit of approach.
Among other goals, this survey intended to identify individuals at age 15 years and above with
evidence or symptoms of chronic cough/wheeze, and a diagnosis in their health passport. It
was also intended to collect data on health seeking costs that chronic coughers incur before
getting a diagnosis, after diagnosis, treatment, hospitalisation as well as guardian costs and
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how health seeking costs incurred by chronic coughers were financed. i.e. financial coping
mechanisms.
Data collection
We administered a validated patient cost questionnaire recommended by the Stop TB Partner-
ship [26] using pre-programmed smartphones. These participants were selected because they
reported costs in relation to their latest confirmed diagnosis through health card/passport. Par-
ticipants with chronic cough were asked to detail their costs including out-of-pocket medical
expenditure (for example administration fees, charges for tests, cost of travel to health facilities
and food during a long trip and at the health facility) and coping mechanisms (money they
borrowed or received from selling assets to cover the cost of diagnosis).
Data analysis
Data analysis was done in STATA v13.1. Direct medical and non-medical costs associated with
chronic cough were summarised using means accompanied by their 95% confidence intervals.
An estimate of variations in costs based on socio-demographic and socio-economic status was
done by looking at how much each category (age, sex, education level and occupation) of
chronic coughers paid to access healthcare. For coping mechanisms, we calculated the absolute
number of chronic coughers who sold assets and/or borrowed money to finance health seeking
costs. Costs were reported in United States Dollar (US$) using April 2015 exchange rate (US
$1 = MK450) from OANDA—https://www.oanda.com/currency/converter/. We collected
information on how much was spent for the preceding 12 months at the time of the survey for
the utilized health services e.g., pre-diagnostics and diagnostic costs, treatment costs, hospitali-
sation costs as well as guardian costs. The specific items costed include administrative, labora-
tory, X-ray, drugs, travel, food as well as accommodation.
Two-part regression analysis was applied to estimate the effect of individuals’ sociodemo-
graphic characteristics on the direct healthcare costs for seeking healthcare due to chronic
cough. The direct costs was a limited dependent variable and was continuous over most of its
distribution but had a mass of observations at zero values. The decision of spending for health-
care and its magnitude might not be statistically independent [27, 28] Applying an Ordinary
Least Square (OLS) estimation method of regression coefficient to only those individuals who
spent for healthcare might result in selection bias [28]. We thus applied a two-part regression
model [27, 29]. The first part estimated the likelihood of incurring any healthcare costs, where
0 meant ‘no cost’ and 1 meant ‘any incurred cost’. This was incorporated in the two-part
model with a logit function. The second part considered the magnitude of the direct healthcare
costs. An ordinary least square function was applied to predict it. Thus the two-part model
used information on both the probability and magnitude of direct costs for healthcare simulta-
neously in assessing the effects of sociodemographic factors of the individuals [30, 31].
Results
Health care costs
There were a total of 608 people, with confirmed diagnosis of CAD in their health card/pass-
port who reported costs in relation to their health care seeking, with a total mean cost of US
$3.9 as illustrated in Table 1.
Table 1 above provides an overview of the mean costs and 95% confidence intervals by type
of direct costs, both medical and non-medical. These costs have been disaggregated into
administration, diagnostic tests, X-ray, drugs, transport, food and accommodation for chronic
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coughers with a confirmed diagnosis in their health passport. Of the total costs incurred by
chronic coughers, drugs and transport form the largest part of the expenditure as evidenced by
US$ 1.3 and US$ 1.4 respectively. We have compared the health care costs of chronic coughers
with the household consumption expenditure in rural Malawi. According to the Malawi Inte-
grated Household Survey of 2010/11, the annual per capita consumption of US$ 107.4 or per
household US$ 494 considering the average household size of 4.6 and inflation rate of 23.4%
per year during 2012–15 [32, 33]. Our estimated health care costs (US$ 3.9) of chronic cough-
ers thus constituted 0.42% of household consumption expenditure. The mean cost was com-
pared against the household consumption expenditure because we wanted to see how much of
the total household consumption expenditure goes to health care seeking.
The magnitude of costs was also dependent on the kind of diagnoses such that some dis-
eases were costlier than others. For instance, Table 2 shows that TB patients incurred the larg-
est average costs ($10.5), followed by the patients with comorbidity ($ 9.4) and Asthma ($ 6.9)
respectively. High costs were a result of transport which patients incur in the course of seeking
diagnosis and getting treatment but also drugs.
Further analysis shows that there were also variations in costs incurred by chronic coughers
with respect to symptoms such that those with breathlessness paid slightly higher costs than
those with other symptoms as seen from Table 3.
It was also observed that there were variations in costs with respect to sociodemographic
and socioeconomic conditions of the chronic coughers (Table 4). The results showed that men
had higher costs (US$ 4.2) than women (US$ 3.9), but the difference was not statistically sig-
nificant. This difference can also be explained by the fact that most women have less money to
spend as such they cannot afford the higher health care seeking costs. However, health seeking
costs increased with age such that those aged 65 and above incurred higher costs (US$ 6.5)
Table 1. Mean health care costs (95% CI) of chronic coughers who reported costs and had confirmed diagnosis in health passport (N = 608).
Type of direct costs Cost component Mean (US$) 95% CI Share % Median (US$) Minimum (US$) Maximum (US$)
Medical Administration 0.3 0.14–0.53 46.7 0.2 0.03 51.1
Diagnostic tests 0.2 -0.00–0.39 2.2 0.02 55.6
X-ray 0.05 0.01–0.10 4.4 0.1 7.8
Drugs 1.3 0.83–1.81 3.3 0.09 110
Sub-total 1.9 1.60–2.58 0.3 0.02 144.4
Non-medical Transport 1.4 1.10–1.74 52.3 2.7 0.02 111.1
Food 0.6 0.40–0.74 0.7 0.02 42.2
Accommodation 0.09 -0.00–0.20 6.7 2.2 26.7
Sub-total 2.09 1.61–2.58 2.2 0.02 113.3
Total cost 3.9 3.00–5.03 100.0 1.8 0.02 188.9
https://doi.org/10.1371/journal.pone.0225712.t001
Table 2. Costs of chronic coughers based on diagnosis.
Diagnosis Observations Mean(US$) 95% CI
TB 17 10.5 -0.72–21.77
Asthma 125 6.9 3.54–10.42
COPD 35 1.1 0.05–2.16
Bronchiectasis 52 0.8 0.21–1.39
LRTI 347 2.9 1.85–3.87
Comorbidity 32 9.4 2.30–16.58
Total 608 3.9 3.00–5.03
https://doi.org/10.1371/journal.pone.0225712.t002
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than those aged below 65 years. Marital status was also a cost determinant such that widows
incurred higher cost (US$ 5.5) than those who are married (US$ 4.2) and divorced (US$ 3.1).
Most chronic coughers who reported health seeking costs had primary level education and
their cost was slightly higher than those without any formal education and those with second-
ary education and above (Table 5). Most of them were farmers while some were casual work-
ers, civil servants and the private sector. Civil servants and private sector employees had higher
costs, though not statistically significant, than any other occupations probably because they
can afford to access health care from the private hospitals which is usually expensive.
Our two-part multiple regression model found that the presence of diseases and comorbid-
ity led to significantly higher chance of incurring any healthcare costs (stage 1 in Table 6). CCs
with COPD and LRTI had 85.6% and 62.0% lower change of incurring any costs compared
with the TB patients. Further, any patients with comorbidity had 2.9 times higher chance to
incur any costs than the patients with single disease. Stage 2 of the regression model (Table 6)
showed that among those who had any healthcare costs, COPD and LRTI patients had 123.9%,
211.4% and 87.9% lower costs than the patients with TB. The patients with comorbidity
incurred 53.9% higher costs than those with single disease.
We, further found that the individuals with occupational attachment to civil service and
private sectors had significantly higher costs (88.9%) than the farmers. No other socioeco-
nomic or demographic factors showed any significant influence on costs for healthcare of the
CCs.
Table 3. Costs of care by symptoms of the chronic coughers.
Symptoms Observations Mean (US$) 95% CI
Cough 289 3.6 2.52–4.69
Cough and blood 48 7.1 2.3–11.91
Wheeze 190 7.0 4.23–9.81
Breathlessness 197 7.1 4.48.– 9.79
Sputum 168 4.4 2.37–6.48
multiple signs are possible
https://doi.org/10.1371/journal.pone.0225712.t003
Table 4. Costs of care considering socio-demographics of chronic coughers.
Sex Observations Mean (US$) (95% CI)
Male 221 4.2 2.08–6.32
Female 387 3.9 2.78–4.97
Age (years)
15–19 48 2.0 0.94–3.13
20–49 363 3.6 2.52–4.71
50–64 115 4.2 1.90–6.46
65 and above 82 6.5 1.46–11.63
Marital status
Married 463 4.2 2.87–5.45
Divorced/separated 42 3.1 1.29–4.90
Widowed 43 5.5 1.19–9.81
Never married 60 2.3 1.30–3.23
Total 608 3.9 3.00–5.03
https://doi.org/10.1371/journal.pone.0225712.t004
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Table 5. Health care costs of chronic coughers with different socio-economic condition.
Socioeconomic group Observations Mean(US$) (95% CI)
Educational level
No formal education 110 3.7 2.91–5.30
Primary level 413 4.1 2.71–5.54
Secondary and above 85 3.8 2.05–5.64
Occupation
Farming 529 3.9 2.82–5.02
Business 21 1.3 -0.25–2.80
Casual work 17 1.8 0.44–3.11
Civil servant 14 14.7 -3.29–32.78
Private sector 1 10
Craftsman 1 0
Remittances 12 3.2 1.19–5.30
Social cash transfer 0 0
https://doi.org/10.1371/journal.pone.0225712.t005
Table 6. Determining factors of healthcare costs.
Variables Description Dependent variable = Direct costs of healthcare for chronic coughing
Stage1. Acquiring cost (logistic
model)
Stage2. Log model of direct
costs
Sex (ref = male) Female 0.945 (1.216) 0.273 (0.187)
Age-group (Ref = 15–19 years) 20–49 years 1.064 (1.625) 0.453 (0.483)
50–64 years 1.037 (1.705) 0.728 (0.728)
65 years and above 1.006 (1.774) 0.728 (0.558)
Marital status (Ref = married) Divorced/separated 0.871 (1.415) -0.132 (0.346)
Widow 1.335 (1.541) -0.301 (0.370)
Never married 0.528 (0.1576) 0.723 (0.454)
Education Ref = No formal
education)
Primary 1.261 (1.275) -0.069 (0.230)
Secondary and above 1.067 (1.434) 0.253 (0.346)
Occupation (Ref = farmer) Business, craftsman 0.528 (1.586) -0.716 (0.551)
Civil servant, Private sector 0.777 (1.797) 0.889� (0.554)
Casual worker, Craftsman, Remittances, Social cash
transfer
1.219 (1.577) -0.357 (0.370)
Disease (Ref = Tuberculosis) Asthma 1.255 (1.777) -0.551 (0.409)
COPD 0.144��� (1.914) -1.239�� (0.605)
Bronchitis 0.505 (1.820) -2.114��� (0.460)
LRTI 0.380� (1.726) -0.879�� (0.404)
Comorbidity (Ref = No) Yes 2.889� (1.794) 0.539� (0.329)
Constant 2.464 (2.129) 6.944��� (0.644)
N 595 346
LRchi2(17) 61.97
Prob. >chi2 0.000
Pseudo R2 0.077
F(17, 328) 3.16
Prob. > F 0.000
Adjusted R2 0.096
���, �� and � denote significant at 1%, 5% and 10% risk level respectively.
https://doi.org/10.1371/journal.pone.0225712.t006
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Financial coping mechanisms
In addition to income and savings, two major coping mechanisms for health care payments
were observed, namely borrowing and selling assets/properties. Our findings in Table 7 below
show that some chronic coughers borrowed money from various sources while others sold
something including household assets. Most borrowing came from the neighbours (41%) fol-
lowed by borrowing from family members (33%) and very few (6%) through bank loans.
Most chronic coughers sold household assets to cover health care costs and the majority of
costs came from selling farm products (58.8%) and livestock (30.4%). See Table 6 above.
Discussion
A total of 608 chronic coughers reported health care costs in relation to their latest illnesses
and the mean total cost was estimated to be US$ 3.9 in a 12-month period. The largest share of
these costs was due to transport (US$ 1.4), followed by medicines (US$1.3). Considering that
the majority of the population where the study was done is poor, the 0.42% of the total house-
hold consumption expenditure is a huge burden. The variations in costs could be described by
demographic and socioeconomic characteristics of the investigated chronic coughers. We
observed that chronic coughers at age of 65 years and above had the largest costs which
reduced with younger ages. This was probably due to the fact that most elderly people required
a guardian to go to the health facility where they sought health care and the costs drove
upwards mainly due to transport, food and accommodation. We also noted that the costs were
higher for widows (US $5.5) than those who were married, divorced/separated and those who
had never been married. However, no clear reasons of such disparities could be identified. Our
multivariate analysis showed that patients with different diseases had significantly different
chance of incurring healthcare costs and that costs varied depending on the type of diseases
and well as the presence of comorbidity.
Our findings, however, were consistent with previous studies, which investigated chronic
coughers’ pathways to seeking health care and the associated costs they incurred in other
Table 7. Distribution of chronic coughers considering the source of borrowing and items (assets/property) of selling.
Mechanism Source Number (N = 87�) Share (%)
Borrowing Family 29 33
Neighbor 36 41
Bank 5 6
Cooperative 14 16
Others 3 3
Total 87 100
Item Number (N = 148��) Share (%)
Selling assets/property Land 1 0.7
Livestock 45 30.4
Vehicle 0 0
Household item 8 5.4
Farm produce 87 58.8
Others 7 4.7
Total 148 100
� One person borrowed from both family and neighbours which means that 86 (not 87) people borrowed because one person was counted on two sources
�� 7 people had multiple responses, meaning that 141 people sold any items.
https://doi.org/10.1371/journal.pone.0225712.t007
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low-income settings [1,21,23,25]. As in Uganda, most chronic cough patients followed
a complex pathway, including herbalist, informal providers and formal providers [9].
According to our findings and those of previous studies, this complex pathway often resulted
in repeated visits to the providers, which possibly contributed to increasing health care
costs.
We do not have scope of estimating the incidence of catastrophic costs of households due
to limitation of data particularly on household income or consumption expenditure. However,
using a proxy measurement of financial protection, this study confirmed that many chronic
coughers sold assets/property and borrowed money to pay for health care. Such findings gave
an indication that the costs of care, even if not very high in absolute terms, were not affordable
for many poor households and might have brought economic impoverishment to some on a
temporary basis if it was not persistent.
We were aware of a limitation of this study regarding recall bias. We used a cross-sectional
survey covering a 12-month period, which might be subject to recall bias while our main
variables of interest dealt with costs of healthcare. Although the bias might be low with the
reported costs of the current visits, we suspect that the costs of previous visits might suffer
more from this recall bias.
Despite this limitation, the study does present important insights into health seeking costs
of chronic coughers and illuminates some coping mechanisms that can cause or perpetuate
poverty. First, while selling of assets can help raise money to cover chronic cough related
expenses, it is important to note that asset sale involving disposal of factors of production like
land may increase the vulnerability of households. Second, borrowing money from family,
friends or money- lenders may represent a reasonable trade-off overtime. However, they can
increase the economic vulnerability of households in the long term, particularly for large
health seeking costs [34].
We propose that further studies on costs of chronic coughers should be done so that costing
data can inform policy makers in the design and provision of universal coverage programs for
core chronic cough health services. Future studies should also look at management of CAD
and TB in relation to cost implication. Addressing major chronic cough challenges that
threaten health and economies alike in low-income settings requires information on the type
and extent of costs incurred by different groups (income groups, geographic regions etc.) of
individuals affected by chronic cough, which can contribute with more knowledge than that
found by this current study. The results from the current study, however, can add to the
knowledge of the policy makers in designing and provision of universal coverage programs for
core chronic cough health services [9, 10 and 12]
Conclusion
The costs of healthcare per chronic cougher was mainly influenced by the costs of transport
and drugs and these costs varied with demographic and socioeconomic characteristics of the
patients. Types of diseases and comorbidity led to significantly different chances of incurring
costs and the magnitude of costs varied significantly. Though the costs were not reportedly
very high as a share of total household consumption expenditure, it appeared to be unafford-
able for many patients.
Supporting information
S1 Data.
(XLSX)
Direct costs of illness of patients with chronic cough in rural Malawi—Dowa and Ntchisi districts
PLOS ONE | https://doi.org/10.1371/journal.pone.0225712 December 31, 2019 9 / 12
Acknowledgments
We would like to acknowledge the tremendous support of our implementing partners during
the lifespan of the study. These include Ministry of Health, Dowa District Health Office,
Ntchisi District Health Office, LHL International, REACH Trust and Liverpool School of
Tropical Medicine. In a special way, I also acknowledge the contribution of Jason Madan,
George Bello and Rasmus Malmbolg during implementation of the study and development of
the manuscript. We also thank the NIHR Global Health Research Unit on Lung Health and
TB in Africa at LSTM—“IMPALA” for helping to make this work possible. In relation to
IMPALA (grant number 16/136/35) specifically: IMPALA was commissioned by the National
Institute of Health Research using Official Development Assistance (ODA) funding. The views
expressed in this publication are those of the author(s) and not necessarily those of the NHS,
the National Institute for Health Research or the Department of Health and Social Care.
Author Contributions
Conceptualization: Ireen Namakhoma, Grace Bongololo, S. Bertel Squire.
Data curation: Junious M. Sichali, Jahangir A. K. Khan, Elvis M. Gama, Hastings T. Banda,
Rachael Thomson.
Formal analysis: Junious M. Sichali, Jahangir A. K. Khan, S. Bertel Squire.
Funding acquisition: Hastings T. Banda, Ireen Namakhoma, Rachael Thomson, S. Bertel
Squire.
Investigation: Junious M. Sichali, Elvis M. Gama, Hastings T. Banda, Grace Bongololo, S. Ber-
tel Squire.
Methodology: Junious M. Sichali, Jahangir A. K. Khan, Elvis M. Gama, Hastings T. Banda,
Ireen Namakhoma, Grace Bongololo, Rachael Thomson, S. Bertel Squire.
Project administration: Junious M. Sichali, Hastings T. Banda, Ireen Namakhoma, Grace
Bongololo.
Resources: Junious M. Sichali, Hastings T. Banda, Ireen Namakhoma, Grace Bongololo,
Berthe Stenberg, S. Bertel Squire.
Software: Ireen Namakhoma, Grace Bongololo.
Supervision: Jahangir A. K. Khan, Elvis M. Gama, Hastings T. Banda, Ireen Namakhoma,
Rachael Thomson, S. Bertel Squire.
Validation: Junious M. Sichali, Jahangir A. K. Khan, Elvis M. Gama, Grace Bongololo, S. Ber-
tel Squire.
Visualization: Jahangir A. K. Khan, Rachael Thomson, S. Bertel Squire.
Writing – original draft: Junious M. Sichali, Jahangir A. K. Khan, Elvis M. Gama, Hastings T.
Banda, Ireen Namakhoma, Grace Bongololo, Rachael Thomson, S. Bertel Squire.
Writing – review & editing: Junious M. Sichali, Jahangir A. K. Khan, Hastings T. Banda,
Grace Bongololo, Rachael Thomson, S. Bertel Squire.
References
1. Aikins AG, Unwin N, Agyemang C, Allotey P, Campbell C, Arhinful D. Tackling Africa’s chronic disease
burden: from the local to the global. Glob Health. 2010; 6:5.
Direct costs of illness of patients with chronic cough in rural Malawi—Dowa and Ntchisi districts
PLOS ONE | https://doi.org/10.1371/journal.pone.0225712 December 31, 2019 10 / 12
2. Martins P, Rosado-Pinto J, do Ce´u Teixeira M, Neuparth N, Silva O, Tavares H, et al. Under-report and
under diagnosis of chronic respiratory diseases in an African country. Allergy. 2009; 64:1061–7. https://
doi.org/10.1111/j.1398-9995.2009.01956.x PMID: 19210360
3. World Health Organization: The Global Burden of Disease: 2004 Update. WHO; 2008
4. Stanciole AE, Ortego´n M, Chisholm D, Lauer JA. Cost effectiveness of strategies to combat chronic
obstructive pulmonary disease and asthma in Sub-Saharan Africa and South East Asia: mathematical
modelling study. BMJ. 2012; 344:e608. https://doi.org/10.1136/bmj.e608 (Published 2 March 2012).
PMID: 22389338
5. Van den Boom M, Seita A, Ottmani S, Migliori GB. Finding the way through the respiratory symptoms
jungle: PAL can help. Eur Respir J. 2010; 36:979–82. https://doi.org/10.1183/09031936.00116810
PMID: 21037364
6. WHO. Burden of COPD. http://www.who.int/respiratory/copd/burden/en/ Accessed May 20–21 2013.
7. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods,
and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, et al., editors. Global burden of disease and
risk factors. Washington (DC): World Bank; 2006. Chapter 3. http://www.ncbi.nlm.nih.gov/books/
nbk11808 (accessed 22 May 2013).
8. Jordan TS, Spencer EM, Davies P. Tuberculosis, bronchiectasis, and chronic airflow obstruction.
Respiralogy. 2010; 16: 623–628.
9. Shete P.B. Haguma P. Miller C.R. Ochom E. Ayakaka I., Davis, et al, 2015. Pathways and costs of care
for patients with tuberculosis symptoms in rural Uganda. The International Journal of Tuberculosis and
Lung Disease, 19(8), pp.912–917. https://doi.org/10.5588/ijtld.14.0166 PMID: 26162356
10. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden for tuberculosis patients in
low- and middleincome countries: a systematic review. Eur Respir J 2014; 43: 1763–1775 https://doi.
org/10.1183/09031936.00193413 PMID: 24525439
11. Bahadori K., Doyle-Waters M.M., Marra C., Lynd L., Alasaly K., Swiston J. et al 2009. Economic burden
of asthma: a systematic review. BMC pulmonary medicine, 9(1), p.1.
12. Madan J., Lo¨nnroth K., Laokri S. and Squire S.B., 2015. What can dissaving tell us about catastrophic
costs? Linear and logistic regression analysis of the relationship between patient costs and financial
coping strategies adopted by tuberculosis patients in Bangladesh, Tanzania and Bangalore, India. BMC
health services research, 15(1), p.1.
13. Blanchette C.M., Roberts M.H., Petersen H., Dalal A.A. and Mapel D.W., 2011. Economic burden of
chronic bronchitis in the United States: a retrospective case-control study. Int J Chron Obstruct Pulmon
Dis, 6, pp.73–81. https://doi.org/10.2147/COPD.S15882 PMID: 21311695
14. Accordini S., Corsico A., Cerveri I., Gislason D., Gulsvik A., Janson C., et al 2008. The socio-economic
burden of asthma is substantial in Europe. Allergy, 63(1), pp.116–124. https://doi.org/10.1111/j.1398-
9995.2007.01523.x PMID: 18053021
15. Guarascio A.J., Ray S.M., Finch C.K. and Self T.H., 2013. The clinical and economic burden of chronic
obstructive pulmonary disease in the USA.ClinicoEconomics and outcomes research: CEOR,
5, pp.235–245.
16. Menzin J., Boulanger L., Marton J., Guadagno L., Dastani H., Dirani R. et al 2008. The economic burden
of chronic obstructive pulmonary disease (COPD) in a US Medicare population. Respiratory medicine,
102(9), pp.1248–1256. https://doi.org/10.1016/j.rmed.2008.04.009 PMID: 18620852
17. Banda HT, Mortimer K, Bello GA, Mbera GB, Namakhoma I, Thomson R, et al, 2015, Informal Health
Provider and Practical Approach to Lung Health interventions to improve the detection of chronic air-
ways disease and tuberculosis at primary care level in Malawi: study protocol for a randomised con-
trolled trial. Trials. 2015 Dec 17; 16:576. http://www.ncbi.nlm.nih.gov/pubmed/26679768
18. Abegunde D.O., Mathers C.D., Adam T., Ortegon M. and Strong K., 2007. The burden and costs of
chronic diseases in low-income and middle-income countries. The Lancet, 370(9603), pp.1929–
1938.
19. Ramsay A, Al-Agbhari N, Scherchand J, Al-Sonboli N, Almotawa A, Gammo M, et al. Direct patient
costs associated with tuberculosis diagnosis in Yemen and Nepal. Int J Tuberc Lung Dis. 2010;
14(2):165–70. PMID: 20074407
20. Barter DM, Agboola SO, Murray MB, Barnighausen T. Tuberculosis and poverty: the contribution of
patient costs in sub-Saharan Africa: a systematic review. BMC Public Health 2012; 12: 980 https://doi.
org/10.1186/1471-2458-12-980 PMID: 23150901
21. Ukwaja KN, Modebe O, Igwenyi C, Alobu I. The economic burden of tuberculosis care for patients and
households in Africa: a systematic review. Int J Tuberc Lung Dis 2012; 16: 733–739. https://doi.org/10.
5588/ijtld.11.0193 PMID: 22410546
Direct costs of illness of patients with chronic cough in rural Malawi—Dowa and Ntchisi districts
PLOS ONE | https://doi.org/10.1371/journal.pone.0225712 December 31, 2019 11 / 12
22. Laokri S, Amoussouhui A, Ouendo EM, et al. A care pathway analysis of tuberculosis patients in Benin:
highlights on direct costs and critical stages for an evidence-based decision-making. PLOS ONE 2014;
9: e96912. https://doi.org/10.1371/journal.pone.0096912 PMID: 24810007
23. Laokri S., Dramaix-Wilmet M., Kassa F., Anagonou S. and Dujardin B., 2014. Assessing the economic
burden of illness for tuberculosis patients in Benin: determinants and consequences of catastrophic
health expenditures and inequities. Tropical Medicine & International Health, 19(10), pp.1249–1258.
24. Sekandi J.N., Dobbin K., Oloya J., Okwera A., Whalen C.C. and Corso P.S., 2015. Cost-effectiveness
analysis of community active case finding and household contact investigation for tuberculosis case
detection in urban Africa. PloS one, 10(2), p.e0117009. https://doi.org/10.1371/journal.pone.0117009
PMID: 25658592
25. Lawson L., Al-Sonboli N., Al-Aghbari N., Arbide I., Sherchand J.B., Nnamdi, et al., 2016. Patients direct
costs to undergo TB diagnosis. Infectious Diseases of Poverty, 5(1), p.1.
26. STOP TB Partnership, 2008, The tool to estimate patients’ costs, http://www.stoptb.org/wg/dots_
expansion/tbandpoverty/assets/documents/Tool%20to%20estimate%20Patients’%20Costs.pdf
27. Okunade AA, Suraratdecha C, Benson DA. Determinants of Thailand household healthcare expendi-
ture: the relevance of permanent resources and other correlates. Health Econ. 2010; 19(3):365–376.
https://doi.org/10.1002/hec.1471 PMID: 19405046
28. Jones A. A double-hurdle model of cigarette consumption. J Appl Econom. 1989; 4(1):23–39.
29. Khan JAM, Ahmed S, Sultana M, Sarker AR, Chakrovorty S, Rahman MH, et al. 2019. The effect of a
Community-Based Health Insurance on the Out-of-pocket Payments for Utilizing Medically Trained Pro-
viders in Bangladesh, Int Health [In press]
30. O’Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Analyzing Health Equity Using Household Sur-
vey Data: A Guide to Techniques and Their Implementation. Washington DC: The World Bank; 2008.
31. Cragg J. Some statistical models for limited dependent variables with application to the demand for
durable goods. Econom J Econom Soc. 1971; 39(5):829–844. http://www.jstor.org/stable/10.2307/
1909582. Accessed January 10, 2014.
32. Malawi National Statistics Office, Integrated Household Survey(HIS) 2010-2011- Household Socio-eco-
nomic characteristic report, 2012, Zomba, Malawi, http://www.nsomalawi.mw/images/stories/data_on_
line/economics/ihs/IHS3/IHS3_Report.pdf
33. United Nations Statistics, Classification of Individual Consumption according to Purpose (COICOP)-
Extract http://www.ilo.org/public/english/bureau/stat/download/cpi/coicop.pdf
34. Kruk M.E., Goldmann E. and Galea S., 2009. Borrowing and selling to pay for health care in low-and
middle-income countries. Health Affairs, 28(4), pp.1056–1066. https://doi.org/10.1377/hlthaff.28.4.
1056 PMID: 19597204
Direct costs of illness of patients with chronic cough in rural Malawi—Dowa and Ntchisi districts
PLOS ONE | https://doi.org/10.1371/journal.pone.0225712 December 31, 2019 12 / 12
